PMA

P890013: RICHARD WOLF PIEZOLITH E.L.P. LITHOTRIPT MODEL2300

FDA PMA · Lithotriptor, extracorporeal shock-wave, urological · Richard Wolf Medical Instruments Corp.

Key facts

PMA number P890013
Trade name RICHARD WOLF PIEZOLITH E.L.P. LITHOTRIPT MODEL2300
Generic name Lithotriptor, extracorporeal shock-wave, urological
Applicant Richard Wolf Medical Instruments Corp.
Owner/operator RICHARD WOLF GMBH
Product code LNS
Approval date Sep 9, 1991
Docket number 91M-0368
Notice date Oct 10, 1991
Establishment registration 1418479
FEI number 1418479

At a glance

  • None Supplements
  • Sep 9, 1991 Latest supplement decision
  • No Withdrawn
  • No Summary of safety and effectiveness on file
  • None UDI device identifiers (GUDID)
  • None MAUDE adverse event reports
  • None Recall events

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About PMA approvals

Premarket approval (PMA) is the FDA's most stringent review pathway, required for most Class III devices that support or sustain life or present a potentially unreasonable risk.

Source: U.S. Food and Drug Administration (FDA), Premarket Approval (PMA) database · Source date:

Browse all PMA approvals